Contract 75N93024C00023
University Of Chicago · Department Of Health And Human Services · September 19, 2024
University Of Chicago was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 19, 2024 for $3.71 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Chicago, IL. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost no fee contract pricing. The most recent modification was on September 24, 2025. If all options are exercised, the contract could reach $9.50 million.
Contract details
- PIID
- 75N93024C00023
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Chicago, IL
- First action
- September 19, 2024
- Latest action
- September 24, 2025
Description
EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING: EOI BILATERAL MODIFICATION TO DESCOPE FOR FY2025 COST SAVINGS: VACCINE ADJUVANT DISCOVERY PROGRAM (VADP)
Modification timeline
-
September 24, 2025Mod P00001 · Change Order$3.71M
-
September 19, 2024Base awardVACCINE ADJUVANT DISCOVERY PROGRAM (VADP)$1.99M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93024C00023?
Contract 75N93024C00023 is a federal contract awarded to University Of Chicago by Department Of Health And Human Services on September 19, 2024 for $3.71 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75N93024C00023?
University Of Chicago won contract 75N93024C00023 from Department Of Health And Human Services.
How much is contract 75N93024C00023 worth?
Contract 75N93024C00023 has obligated $3.71 million to date, with a total potential value of $9.50 million if all options are exercised.